drugset / Trial / NCT04607512
Study to Evaluate the ECG Effects of Telaglenastat in Healthy Adult Subjects
RandomizedCrossoverQuadruple-blindOther
Summary
This study is designed to evaluate the effects of telaglenastat on cardiac repolarization (relative to placebo) in healthy adult subjects.
Timeline
- Start
- 2020-10-05
- Primary completion
- 2020-12-30
- Completion
- 2020-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CB-839 | Unknown | 800 mg | — |
Indications
No indication recorded.